Investigation Into the Microorganisms in Pregnant Women

Sponsor
Chinese University of Hong Kong (Other)
Overall Status
Recruiting
CT.gov ID
NCT04688866
Collaborator
Hallym University (Other), Health and Medical Research Fund (Other)
200
1
162.9
1.2

Study Details

Study Description

Brief Summary

Pregnant women with short cervical length (<25 mm) in second-trimester ultrasonographic assessment are at high risk for preterm birth, a major cause of perinatal mortality and morbidity worldwide. Some of these short-cervix women proceed to a more advanced stage manifested as a painless prematurely dilated cervix in the second trimester. It is not fully understood why some women have short cervical length or prematurely dilated cervix (cervical insufficiency), although evidence is mounting that there is an association between short cervical length and infection by microorganisms. The investigators hypothesize that the cervical microorganisms in pregnant women with a shortened or dilated cervix are different, compared with those in women with normal cervical length and a closed cervix.

Condition or Disease Intervention/Treatment Phase
  • Other: Sequencing

Detailed Description

Previously, culture-dependent methods were used to detect bacterial or fungal infection, but the sensitivity was low, since not all species grew well in culture. Recently, molecular methods based on PCR amplification of the bacterial 16S ribosomal RNA (rRNA) gene or the fungal internal transcribed spacer (ITS) followed by capillary sequencing has been used to identify bacteria and fungi. However, the resolution of such capillary sequencing-based method (<100 sequencing reads/sample) is too low to capture the major collection of microorganisms in a sample. Less abundant but possibly pathogenic microorganisms associated with short cervical length remain undetectable. To address the current gap in this field, we propose to more comprehensively survey microbial communities in the cervix of pregnant women by PCR amplification of the 16S rRNA region, ITS or other genomic regions with taxonomic classification potential. This will be followed by next-generation sequencing (>40,000 sequencing reads/sample), which has been proven to capture the majority of microorganisms in a sample.

Study Design

Study Type:
Observational
Anticipated Enrollment :
200 participants
Observational Model:
Case-Control
Time Perspective:
Retrospective
Official Title:
Investigation Into the Fungal Microbiome (Mycobiome) in the Cervices of Cervical Insufficiency Patients Receiving Cerclage Treatment and Resulting in Term or Preterm Birth
Actual Study Start Date :
Jun 5, 2012
Anticipated Primary Completion Date :
Dec 31, 2025
Anticipated Study Completion Date :
Dec 31, 2025

Arms and Interventions

Arm Intervention/Treatment
Pregnant women with cervical insufficiency (Cases)

Pregnant women with a shortened (<25 mm) or dilated cervix in the second trimester (or late first trimester)

Other: Sequencing
This is an observational study, since the assignment of the medical intervention (e.g. cerclage or pessary) is not at the discretion of the investigator. However, cervical samples collected from both groups are subjected to amplicon sequencing for taxonomic classification of microorganisms.

Pregnant women without cervical insufficiency (Controls)

Pregnant women with a normal-length (>= 25 mm) and closed cervix in the second trimester (or late first trimester)

Other: Sequencing
This is an observational study, since the assignment of the medical intervention (e.g. cerclage or pessary) is not at the discretion of the investigator. However, cervical samples collected from both groups are subjected to amplicon sequencing for taxonomic classification of microorganisms.

Outcome Measures

Primary Outcome Measures

  1. Abundances of microorganisms in the cervix [1 year]

    Abundances of microorganisms including bacteria and fungi in the cervix are measured by normalized sequencing read counts

Secondary Outcome Measures

  1. Gestational age at delivery [1 year]

  2. Mode of delivery [1 year]

  3. Number of participants who received cerclage or ring pessary in the current pregnancy [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Women with or without cervical insufficiency (cervical length <25 mm or dilated cervix in the second trimester or the late first trimester)
Exclusion Criteria:
  • multiple pregnancies and pregnancies associated with fetal chromosomal abnormality

Contacts and Locations

Locations

Site City State Country Postal Code
1 Research Laboratory, Dept of Obstetrics & Gynaecology, The Chinese University of Hong Kong Hong Kong Hong Kong 852

Sponsors and Collaborators

  • Chinese University of Hong Kong
  • Hallym University
  • Health and Medical Research Fund

Investigators

  • Principal Investigator: Stephen S Chim, PhD, Chinese University of Hong Kong

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stephen Chim, Associate Professor, Chinese University of Hong Kong
ClinicalTrials.gov Identifier:
NCT04688866
Other Study ID Numbers:
  • 2012.243
First Posted:
Dec 30, 2020
Last Update Posted:
Mar 10, 2022
Last Verified:
Mar 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Stephen Chim, Associate Professor, Chinese University of Hong Kong
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 10, 2022